AI GxP validation for regulated life sciences
AI Governance

AI in the QC Lab: Where It Helps and Where It Must Not Decide

Chromatography review, OOS triage, stability trending and method transfer are the lab's slowest work. What AI can genuinely take on, what has to stay an analyst's call, and why lab data integrity history makes this area sensitive.

Cybroscape Technologies6 min read

Key takeaway

Chromatography review, OOS triage, stability trending and method transfer are the lab's slowest work. What AI can genuinely take on, what has to stay an analyst's call, and why lab data integrity history makes this area sensitive.

The QC lab is an obvious target. Chromatography review, stability trending, OOS investigations and method transfer absorb enormous amounts of analyst time, much of it spent reading data that looks exactly like the data they read yesterday.

It is also the most sensitive place in the building to put a machine, because the lab is where most data integrity findings in this industry have originated. That history shapes what is sensible here.

Where it genuinely helps

  • Chromatogram review triage. Flagging peaks that need a second look — poor resolution, unexpected shoulders, integration that drifted from the method. The analyst still reviews; the system decides the order and highlights what is unusual.
  • Stability trending. Spotting a drift toward a specification limit several timepoints before it would trigger a formal alert. A well-matched problem: lots of numbers, slow-moving signal, costly if missed.
  • Finding similar past investigations. "This OOS pattern on this column has happened four times, three of them traced to the same mobile phase batch."
  • Method transfer comparison. Comparing two sites' data for systematic differences that a human eye averages out.
  • Drafting investigation narratives from the analyst's findings, in the format the SOP requires.
  • Audit trail review support. Surfacing the entries that deserve attention from thousands that do not — see audit trail review.

What must stay with the analyst

Integration decisions. Where a peak starts and ends changes the result. This is the single most scrutinised judgement in a QC lab and the one with the longest history of regulatory concern. A system may propose integration; an analyst accepts it, and the record shows who did.

Whether a result is valid. Invalidating a result requires a scientific justification by a qualified person. No automation.

OOS root cause and the decision to retest. The retest decision is exactly where inspectors look hardest, for good reason.

Release. Not a borderline case — a named person certifies.

The pattern is consistent with everything else in regulated AI: the system proposes and prioritises, a qualified person decides, and the decision carries a name. See roles and responsibilities.

Why this area needs extra care

Most published data integrity findings in this industry trace back to laboratory systems — shared logins, audit trails switched off, trial injections run before the reportable result. An inspector arriving at a lab that has introduced AI will reasonably ask whether the new system makes selective reporting easier or harder to detect.

The answer should be "harder", and you should be able to show it. If your tool surfaces every injection including the discarded ones, that is a data integrity improvement you can demonstrate. If it only ever sees the reportable run, it has inherited the blind spot.

Build the question into your requirements rather than discovering the answer later. See data integrity and the recurring lab findings.

Validating it

The lab system itself is almost certainly already validated. The AI layer is a change to it, which means an impact assessment and testing proportionate to what the layer does — triage and prioritisation sit much lower on the risk scale than anything touching a reported result.

Write the intended use tightly: "prioritises chromatograms for review and highlights atypical features; does not integrate peaks, assign results or determine validity" is the kind of sentence that keeps the risk assessment, the testing and the inspection conversation all short.

Method in GxP AI validation, scoping in the intended use statement, and platform context in LIMS validation.

Where to go next

Explore Cybroscape GxP Copilot for AI-native validation, Cybroscape TraceDraft for source-traceable clinical documentation, or book a demo to see either on your own data.

AI drafts
AI-drafted
Source linked
Your reviewerApprove and signSend back with comments
Signed record
  • Signer’s name
  • Date and time
  • Meaning of the signature
  • Entry in the audit trail
The AI never approves its own work
Where the AI stops: it drafts and links each statement to its source. A qualified person reviews, edits and signs. Only the signed version becomes the record.
See it on your own systemBring a URS or a system. We run GxP Copilot against it live on the call.
ai qc laboratoryai chromatography reviewai oos investigationai stability trending
FAQ

Frequently Asked Questions

Prefer to talk first? Chat with us on WhatsApp or book a call with an expert.

Where does AI help in a QC laboratory?

Chromatogram review triage (flagging peaks needing a second look and ordering the queue), stability trending to spot drift toward a limit early, finding similar past investigations, method transfer comparison between sites, drafting investigation narratives from the analyst's findings, and supporting audit trail review by surfacing entries that deserve attention.

What must stay with the analyst in a QC lab?

Integration decisions, because where a peak starts and ends changes the result and it is the most scrutinised judgement in the lab; whether a result is valid; OOS root cause and the decision to retest; and release, which a named person certifies. The system proposes and prioritises; a qualified person decides.

Why is the QC lab especially sensitive for AI?

Because most published data integrity findings in this industry trace back to laboratory systems — shared logins, audit trails disabled, trial injections before the reportable run. An inspector will ask whether the new system makes selective reporting easier or harder to detect, and the answer should be 'harder', demonstrably.

Does an AI layer need separate validation?

The lab system is already validated, so the AI layer is a change to it: impact assessment plus testing proportionate to what the layer does. Triage and prioritisation sit far lower on the risk scale than anything touching a reported result.

How should the intended use be written?

Tightly, naming the exclusions. For example: prioritises chromatograms for review and highlights atypical features; does not integrate peaks, assign results or determine validity. That one sentence keeps the risk assessment, the testing and the inspection conversation short.

Keep reading

All articles
AI GovernanceYour Data Probably Isn't Ready for AI. Here's How to TellThe step nobody budgets for. How to judge whether your deviations, batch records and documents can actually support an AI project, what to fix first, and why a model trained on inconsistent history learns the inconsistency. · 6 min readAI GovernanceThe EU AI Act and life sciences: less than you fear, plus one thing you missedMost GxP AI is not high-risk under the EU AI Act. Medical device AI and AI used in hiring or performance decisions are, and the AI literacy duty has applied to every company using AI since February 2025. · 3 min readAI GovernanceCan You Use Microsoft Copilot or ChatGPT in a GxP Environment?The question every quality team is being asked. Where general-purpose AI assistants are fine in a regulated company, where they are not, why they cannot produce Part 11 records, and how to write a policy people will follow. · 7 min readAI GovernanceThe White House SI Accord: What "Internal Controls and Layers of Audits" Actually MeansThe industry accord signed alongside the order is voluntary and, in the President's words, morally binding. What its commitments would mean if taken seriously, and how they compare with what GMP has required of computerised systems for decades. · 5 min readAI GovernanceWhy Quality Teams Resist AI, and What Actually Changes Their MindsThe resistance is usually rational, and treating it as a training problem makes it worse. What quality professionals are actually objecting to, which arguments land, and the one demonstration that moves people. · 6 min readAI GovernanceAI for Deviation Investigations and CAPA: What Works and What Doesn'tWhere AI genuinely helps with deviations and CAPA (triage, similar-case retrieval, drafting), what must stay a human decision under GMP, and the failure mode that quietly reinforces bad root causes. · 6 min readAI GovernanceAI governance for Life Sciences: the operating model that actually shipsPolicies, model registry, use-case intake, HITL policy, drift, red-teaming: engineered for regulated environments. · 6 min readAI GovernanceAI Governance for Life Sciences: a Practical Guide with TemplatesA practical operating model for regulated AI governance: policies, model registry, use-case intake, HITL, drift and incident response. · 3 min read

Bring a system. We'll show you the package.

Book a demo, or ask a validation lead a quick question on WhatsApp.

  • We reply within one business day
  • We run your URS live on the call
  • You get a clear plan for your system
Chat on WhatsApp

Book a demo

Four fields. The right specialist replies within one business day.

Your details stay private. We never share them.